High-throughput screening identifies aclacinomycin as a radiosensitizer of EGFR-mutant non-small cell lung cancer

Daniel C. Bennett, Jonathan Charest, Katrina Sebolt, Mark Lehrman, Alnawez Rehemtulla, Joseph N. Contessa

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'High-throughput screening identifies aclacinomycin as a radiosensitizer of EGFR-mutant non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences